MARKET

PDSB

PDSB

Pds Biotechnology Corporation
NASDAQ
2.825
-0.175
-5.83%
Opening 11:36 06/14 EDT
OPEN
2.970
PREV CLOSE
3.000
HIGH
2.979
LOW
2.810
VOLUME
116.25K
TURNOVER
0
52 WEEK HIGH
6.92
52 WEEK LOW
2.590
MARKET CAP
103.62M
P/E (TTM)
-2.0556
1D
5D
1M
3M
1Y
5Y
PDS Biotechnology Price Target Maintained With a $21.00/Share by HC Wainwright & Co.
Dow Jones · 1d ago
HC Wainwright & Co. Reiterates Buy on PDS Biotechnology, Maintains $21 Price Target
Benzinga · 1d ago
PDS Biotechnology Price Target Cut to $9.00/Share From $11.00 by B. Riley Securities
Dow Jones · 2d ago
PDS Biotechnology Is Maintained at Buy by B. Riley Securities
Dow Jones · 2d ago
B. Riley Securities Maintains Buy on PDS Biotechnology, Lowers Price Target to $9
Benzinga · 2d ago
H.C. Wainwright Keeps Their Buy Rating on PDS Biotechnology (PDSB)
TipRanks · 2d ago
PDS BIOTECH PROVIDES DATA UPDATE FROM ONGOING VERSATILE-002 PHASE 2 CLINICAL TRIAL IN HEAD AND NECK CANCER
Reuters · 2d ago
Weekly Report: what happened at PDSB last week (0603-0607)?
Weekly Report · 4d ago
More
About PDSB
PDS Biotechnology Corporation is a clinical-stage immunotherapy company. The Company is developing a pipeline of targeted cancer immunotherapies based on its Versamune T cell-activator and Versamune in combination with its interleukin 12 (IL-12) fused antibody drug conjugate (ADC), PDS01ADC, a tumor targeting immunocytokine. PDS0101 is its lead Versamune based immunotherapy. PDS0101 combines Versamune with a mixture of short proteins (peptides) derived from the cancer-causing HPV16 viral protein. Versamune is a proprietary lipid nanoparticle and T cell activating platform. PDS0301 is an investigational tumor-targeting antibody conjugate of Interleukin 12 (IL-12) that enhances the proliferation, potency, infiltration, and longevity of T cells in the tumor microenvironment. Its Versamune immunotherapies and Versamune in combination with PDS01ADC, are utilized for treatments in oncology, and Infectimune is utilized for preventive vaccines against infectious agents.

Webull offers PDS Biotechnology Corp stock information, including NASDAQ: PDSB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PDSB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PDSB stock methods without spending real money on the virtual paper trading platform.